Helen Athena Fulbright

Search results

• 2025

  Adagrasib for previously treated KRAS G12C mutation positive advanced non-small-cell lung cancer: A Single Technology Appraisal

  Llewellyn, A., Layne, R. J. L., Umemneku-Chikere, C., Chivardi, C., Fulbright, H., Dias, S., Rothery, C., Kirkham, K. M. & Duarte, A. I., 9 May 2025, National Institute for Health and Care Excellence.

  Research output: Book/Report › Commissioned report

• Belantamab mafodotin with bortezomib and dexamethasone for treating relapsed or refractory multiple myeloma after 1 or more treatments: A Single Technology Appraisal

  Uphoff, N., Layne, R. J. L., Gibbs, N. K., Anwer, S., Melton, H. A., Fulbright, H., Parrish, C., Corbett, M. S., Rothery, C., Dias, S. & Duarte, A. I., 24 Jun 2025, National Institute for Health and Care Excellence.

  Research output: Book/Report › Commissioned report

• Cerliponase alfa for treating neuronal ceroid lipofuscinosis type 2 (review of HST12): A Highly Specialised Technology Evaluation

  Duarte, A. I., Corbett, M. S., Zhou, A., Umemneku-Chikere, C., Fulbright, H., Kunst, N. & Simmonds, M. C., 15 May 2025, National Institute for Health and Care Excellence.

  Research output: Book/Report › Commissioned report
• 2024

  Avapritinib for treating advanced systemic mastocytosis

  Shepherd, L., Phung, H., Gibbs, N. K., Wade, R., Gao, M., Fulbright, H., Dias, S. & Rothery, C., 3 Oct 2024

  Research output: Book/Report › Commissioned report

• Bereavement support and Prolonged Grief Disorder: scoping and mapping the evidence. Final report

  Raine, G. A., Khouja, C. L., Khatwa, M., Fulbright, H., Sutcliffe, K. & Sowden, A. J., 22 May 2024, London. 89 p.

  Research output: Book/Report › Commissioned report

  File

• Cardiovascular risk communication: Systematic review of qualitative evidence

  Lorenc, T., Stokes, G., Fulbright, H., Sutcliffe, K. & Sowden, A. J., 2024, 94 p.

  Research output: Book/Report › Commissioned report

  Open Access

• Exagamglogene autotemcel for treating transfusion-dependent beta-thalassaemia

  Deng, J., Corbett, M. S., Uphoff, N., Lord, J., Fulbright, H., Griffin, S., Rothery, C. & Hodgson, R., 2 Aug 2024, National Institute for Health and Care Excellence.

  Research output: Book/Report › Commissioned report

• Iptacopan for treating paroxysmal nocturnal haemoglobinuria: A Single Technology Appraisal

  Rodgers, M., Kunst, N., Umemneku-Chikere, C., Zhou, A., Gao, M., Fulbright, H. A., Eastwood, A. J. & Rothery, C., 2024, National Institute for Health and Care Excellence.

  Research output: Book/Report › Commissioned report

• Lorlatinib for untreated ALK-positive advanced non-small-cell lung cancer (Review of TA909)

  Llewellyn, A., Coughlan, D., Umemneku-Chikere, C., Fulbright, H., Nevitt, S. J. & Hodgson, R., 15 Nov 2024, National Institute for Health and Care Excellence.

  Research output: Book/Report › Commissioned report

• Olaparib with abiraterone for untreated hormone-relapsed metastatic prostate cancer

  Corbett, M. S., Deng, J., Uphoff, N., Walton, M. J., Lord, J., Fulbright, H. A., Dwan, K. & Hodgson, R., 7 Feb 2024, National Institute for Health and Care Excellence.

  Research output: Book/Report › Commissioned report

• Psychosocial consequences of weight monitoring in children: Systematic review and policy mapping

  Lorenc, T., Burchett, H., D'Souza, P., Fulbright, H., Sowden, A. J., Sutcliffe, K. & Thomas, J., 2024, 85 p.

  Research output: Book/Report › Commissioned report

  Open Access

• Treatment and rehabilitation of Long COVID: A scope of the literature. Update July 2024

  Raine, G. A., Khouja, C. L., Fulbright, H., Sutcliffe, K. & Sowden, A. J., 9 Sept 2024, London: EPPI-Centre, Social Science Research Unit, UCL Institute of Education, University College London. 31 p.

  Research output: Book/Report › Commissioned report

  Open Access

  File

• Treatment and rehabilitation of Long COVID: A scope of the literature. Update April 2024

  Raine, G. A., Khouja, C. L., Fulbright, H., Sutcliffe, K. & Sowden, A. J., 6 Jun 2024, London: EPPI-Centre, Social Science Research Unit, UCL Institute of Education, University College London. 28 p.

  Research output: Book/Report › Commissioned report

  Open Access

  File

• Ublituximab for treating relapsing multiple sclerosis: A Cost Comparison Evaluation

  Zhou, A., Uphoff, N., Corbett, M. S., Fulbright, H., Rothery, C. & Simmonds, M. C., 29 Nov 2024, National Institute for Health and Care Excellence.

  Research output: Book/Report › Commissioned report
• 2023

  Ciltacabtagene autoleucel for treating relapsed or refractory multiple myeloma

  Llewellyn, A., Murphy, P. J., Beresford, L., Walton, M. J., Fulbright, H. A., Harden, M., Eastwood, A. J. & Hodgson, R., 17 May 2023, National Institute for Health and Care Excellence.

  Research output: Book/Report › Commissioned report

• Cipaglucosidase alfa with miglustat for treating Pompe disease

  Wade, R., Deng, J., Dwan, K., Robertson, L., Uphoff, N., Fulbright, H. A., Dias, S., Hodgson, R. & Eastwood, A. J., 15 Aug 2023, National Institute for Health and Care Excellence.

  Research output: Book/Report › Commissioned report

• Dabrafenib plus trametinib for treating BRAF V600 mutation-positive advanced non-small-cell lung cancer

  Walton, M. J., Corbett, M. S., Dwan, K., Njoroge, M. W., Fulbright, H. A., Uphoff, N., Hodgson, R. & Dias, S., 11 May 2023, National Institute for Health and Care Excellence.

  Research output: Book/Report › Commissioned report

• Dupilumab for treating prurigo nodularis: External Assessment Group Report for the National Institute for Health and Care Excellence

  Corbett, M. S., Zhou, A., Anwer, S., Wade, R., Chen, T., Fulbright, H. A., Bojke, L., Eastwood, A. J. & Rothery, C., Aug 2023, National Institute for Health and Care Excellence.

  Research output: Book/Report › Commissioned report

• Glofitamab for treating relapsed or refractory diffuse large B-cell lymphoma after 2 or more systemic treatments. External Assessment Group Report

  Saramago Goncalves, P. R., Rodgers, M., Premji, S., Uphoff, N., Gao, M., Fulbright, H. A., Duarte, A. I. & Simmonds, M. C., 17 Oct 2023

  Research output: Book/Report › Commissioned report

• Pembrolizumab plus chemotherapy with or without bevacizumab for persistent, recurrent or metastatic cervical cancer (Rapid Review of TA885)

  Walton, M. J., Rodgers, M., Fulbright, H. A., Eastwood, A. J. & Hodgson, R., 13 Dec 2023, National Institute for Health and Care Excellence.

  Research output: Book/Report › Commissioned report

• Pembrolizumab with chemotherapy for treating recurrent, persistent or metastatic cervical cancer [ID3798]Pembrolizumab with chemotherapy for treating recurrent, persistent or metastatic cervical cancer

  Rodgers, M., Walton, M. J., Anwer, S., Corbett, M. S., Njoroge, M. W., Fulbright, H. A., Naik, R., Powell, M., Eastwood, A. J. & Hodgson, R., 29 Mar 2023, National Institute for Health and Care Excellence.

  Research output: Book/Report › Commissioned report

• Tofacitinib for treating active ankylosing spondylitis: A Fast Track Appraisal. Evidence Review Group Report for the National Institute for Health and Care Excellence

  Corbett, M. S., Walker, R. A. E., Anwer, S., Shepherd, L., Walton, M. J., Fulbright, H. A., Phung, H., Soares, M. O., Rothery, C., Duarte, A. I. & Dias, S., 18 Oct 2023, National Institute for Health and Care Excellence.

  Research output: Book/Report › Commissioned report

• 2022

  Devices for remote continuous monitoring of people with Parkinson’s disease: A Diagnostics Assessment Report for the National Institute for Health and Care Excellence

  Cox, E. M., Wade, R., Hodgson, R., Fulbright, H. A., Phung, H., Meader, N., Walker, S. M., Rothery, C. & Simmonds, M. C., 2022, National Institute for Health and Care Excellence.

  Research output: Book/Report › Commissioned report

• Upadacitinib for treating active ankylosing spondylitis: A Fast Track Appraisal. Evidence Review Group Report for the National Institute for Health and Care Excellence

  Walker, R. A. E., Corbett, M. S., Beresford, L., Anwer, S., Duarte, A. I., Fulbright, H. A., Phung, H., Soares, M. O., Rothery, C., Walton, M. J. & Dias, S., 2022, National Institute for Health and Care Excellence.

  Research output: Book/Report › Commissioned report
• 2021

  Daratumumab in combination for newly diagnosed systemic amyloid light-chain amyloidosis: Evidence Review Group Report for the National Institute for Health and Care Excellence

  Faria, R., Rodgers, M., Saramago Goncalves, P. R., Anwer, S., Fulbright, H. A., Lachmann, H., Wechalekar, A., Dias, S. & Rothery, C., 2021, National Institute for Health and Care Excellence.

  Research output: Book/Report › Commissioned report